These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6539515)

  • 1. Human ureter, a source of tissue plasminogen activator.
    Ljungnér H; Astedt B; Bergqvist D; Pandolfi M
    Thromb Res; 1984 May; 34(3):217-24. PubMed ID: 6539515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K; Dohi K; Fujii Y; Ishikawa H
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological characterization of plasminogen activators in human mixed saliva.
    Kjaeldgaard A; Kjaeldgaard M
    Acta Physiol Scand; 1986 Mar; 126(3):443-7. PubMed ID: 3515850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased fibrinolytic activity in vessels and ureters of rejecting human kidneys.
    Ljungnér H; Bergqvist D; Husberg B; Bergentz SE
    Scand J Urol Nephrol; 1983; 17(3):361-4. PubMed ID: 6359388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of plasminogen activators in unstimulated and stimulated human whole saliva.
    Sindet-Pedersen S; Gram J; Jespersen J
    J Dent Res; 1987 Jun; 66(6):1199-203. PubMed ID: 3114346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of epitopes on human tissue plasminogen activator recognised by a group of monoclonal antibodies.
    MacGregor IR; Micklem LR; James K; Pepper DS
    Thromb Haemost; 1985 Feb; 53(1):45-50. PubMed ID: 2581330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of plasminogen activator produced by an established cell line from human ovary.
    Matsuo C; Fukao H; Matsuo O
    J Cell Physiol; 1988 Feb; 134(2):253-60. PubMed ID: 3126195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological characterisation of plasminogen activators in the human vessel wall.
    Ljungnér H; Holmberg L; Kjeldgaard A; Nilsson IM; Astedt B
    J Clin Pathol; 1983 Sep; 36(9):1046-9. PubMed ID: 6684128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cells.
    Bykowska K; Levin EG; Rijken DC; Loskutoff DJ; Collen D
    Biochim Biophys Acta; 1982 Apr; 703(1):113-5. PubMed ID: 7200373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study.
    Bernik MB; Kwaan HC
    J Clin Invest; 1969 Sep; 48(9):1740-53. PubMed ID: 5822582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis in cornea and conjunctiva: evidence of two types of activators.
    Lantz E; Pandolfi M
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(5):393-6. PubMed ID: 3530882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator in psoriatic scales is of the tissue-type PA as identified by monoclonal antibodies.
    Grøndahl-Hansen J; Nielsen LS; Kristensen P; Grøndahl-Hansen V; Andreasen PA; Danø K
    Br J Dermatol; 1985 Sep; 113(3):257-63. PubMed ID: 3933538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal and immunological characterization of the cell-associated plasminogen activators produced by cultured rat granulosa cells.
    Knecht M
    Endocrinology; 1987 May; 120(5):2174-9. PubMed ID: 3032577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activator.
    Lijnen HR; Dewerchin M; De Cock F; Collen D
    Thromb Res; 1990 Feb; 57(3):333-42. PubMed ID: 2107593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA].
    Ieko M
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.
    Gurewich V; Pannell R
    Thromb Res; 1986 Oct; 44(2):217-28. PubMed ID: 3097872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.